Literature DB >> 2821553

Influence of kinetics of nicotine administration on tolerance development and receptor levels.

M J Marks1, J A Stitzel, A C Collins.   

Abstract

Nicotine was administered intravenously to DBA mice through cannulae implanted in the jugular veins. Five groups of animals were treated: a control group which received saline and four nicotine treatment groups. All of the nicotine treatment groups received a dose of 4.0 mg/kg/hr. The first group received continuous infusion, the second group received 1 mg/kg pulses four times an hour, the third group received 2 mg/kg pulses twice an hour, and the fourth group received 4 mg/kg pulses once an hour. After a 10-day treatment period, the animals were tested for tolerance to an acute intraperitoneal administration of nicotine. Tolerance was measured using a test battery composed of the following tests: respiratory rate, acoustic startle response, Y-maze crosses and rears, heart rate, and body temperature. Mice from each of the four nicotine treatment groups were tolerant to the acute effect of nicotine, but the extent of tolerance varied among the groups as follows: continuous infusion less than 1 mg/kg pulses four times/hr less than 2 mg/kg pulses twice/hr less than 4 mg/kg pulse once/hr. Chronic nicotine infusion resulted in significant increases in the binding of L-[3H]nicotine in all six brain regions assayed and in significant increases in the binding of alpha-[125I]bungarotoxin binding in cerebral cortex and hippocampus. All increases in binding resulted from increases in Bmax for these ligands. In contrast to the effects observed for tolerance development, the increases in [3H]nicotine binding were not significantly affected by the kinetics of nicotine infusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821553     DOI: 10.1016/0091-3057(87)90355-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  12 in total

1.  Environment-specific tolerance to nicotine.

Authors:  L H Epstein; A R Caggiula; R Stiller
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Chronic and acute tolerance to the heart rate effects of nicotine.

Authors:  K A Perkins; L H Epstein; R L Stiller; B L Marks; R G Jacob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Acute stress or corticosterone administration reduces responsiveness to nicotine: implications for a mechanism of conditioned tolerance.

Authors:  A R Caggiula; L H Epstein; S M Antelman; S Saylor; S Knopf; K A Perkins; R Stiller
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 4.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

5.  Α4β2 and α7 nicotinic acetylcholine receptor binding predicts choice preference in two cost benefit decision-making tasks.

Authors:  I A Mendez; J C Damborsky; U H Winzer-Serhan; J L Bizon; B Setlow
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

6.  Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.

Authors:  Alexey G Mukhin; Alane S Kimes; Svetlana I Chefer; John A Matochik; Carlo S Contoreggi; Andrew G Horti; D Bruce Vaupel; Olga Pavlova; Elliot A Stein
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

7.  Adrenalectomy reverses chronic injection-induced tolerance to nicotine.

Authors:  E A Grun; J R Pauly; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  An analysis of response to nicotine infusion using an automated radiotelemetry system.

Authors:  S F Robinson; J R Pauly; M J Marks; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

Review 9.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

Review 10.  A systematic review of possible serious adverse health effects of nicotine replacement therapy.

Authors:  Peter N Lee; Marc W Fariss
Journal:  Arch Toxicol       Date:  2016-10-03       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.